SCHEMBL14136247

SCHEMBL14136247

Cc1c(C(=O)N(C)O)ccc2cccnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
EGLN1 Q9GZT9 6/20 0.45
NPC1 O15118 1/20 0.45
CASP3 P42574 1/20 0.45
RAB9A P51151 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
LMNA P02545 3/20 0.44
KDM4E B2RXH2 3/20 0.44
CCR1 P32246 3/20 0.44
CCR5 P51681 3/20 0.44
CCR8 P51685 3/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
GMNN O75496 1/20 0.44
TP53 P04637 1/20 0.44
HSP90AA1 P07900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL643192 0.84 ALDH1A1 (0.46) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL13943232 0.81 ALDH1A1 (0.54) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL644794 0.81 ALDH1A1 (0.68) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL3502575 0.77 KDM4E (0.56) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL15445449 0.77 ALDH1A1 (0.50) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL9983599 0.76 ALDH1A1 (0.49) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL23714060 0.74 EGLN1 (0.56) ALDH1A1EGLN1NPC1CASP3RAB9A
SCHEMBL18069879 0.72 ALDH1A1 (0.49) ALDH1A1EGLN1KDM4EMAPTHTT
SCHEMBL4961749 0.71 PARP1 (0.62) ALDH1A1NPC1CASP3RAB9ASENP8
Phenanthroline SCHEMBL28097109 0.70 LMNA (0.73) ALDH1A1EGLN1LMNAKDM4ECCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396849-B2 4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonists ALLERGAN, INC. (US) 2008-07-08 US disclosed